CLDN19 Gene Hypomagnesemia type 5 Genetic Test
Test Name: CLDN19 Gene Hypomagnesemia type 5 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CLDN19 Gene Hypomagnesemia type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 5.
Test Details
The CLDN19 gene is associated with a condition called hypomagnesemia type 5. Hypomagnesemia is a condition characterized by low levels of magnesium in the blood. This type of hypomagnesemia is caused by mutations in the CLDN19 gene.
NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that allows for the sequencing of multiple genes simultaneously. It is a powerful tool that can identify mutations or variations in the CLDN19 gene that may be causing hypomagnesemia type 5.
NGS genetic testing for CLDN19 gene mutations can be used to diagnose individuals with hypomagnesemia type 5 and to identify carriers of the mutation. It can also be used for prenatal testing in families with a known CLDN19 gene mutation.
Genetic testing can provide valuable information for the management and treatment of individuals with hypomagnesemia type 5. It can help guide medical interventions and inform genetic counseling for affected individuals and their families.
Test Name | CLDN19 Gene Hypomagnesemia type 5 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CLDN19 Gene Hypomagnesemia type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 5 |
Test Details |
The CLDN19 gene is associated with a condition called hypomagnesemia type 5. Hypomagnesemia is a condition characterized by low levels of magnesium in the blood. This type of hypomagnesemia is caused by mutations in the CLDN19 gene. NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that allows for the sequencing of multiple genes simultaneously. It is a powerful tool that can identify mutations or variations in the CLDN19 gene that may be causing hypomagnesemia type 5. NGS genetic testing for CLDN19 gene mutations can be used to diagnose individuals with hypomagnesemia type 5 and to identify carriers of the mutation. It can also be used for prenatal testing in families with a known CLDN19 gene mutation. Genetic testing can provide valuable information for the management and treatment of individuals with hypomagnesemia type 5. It can help guide medical interventions and inform genetic counseling for affected individuals and their families. |